SGLT2 Inhibitors and Cardiorenal Outcomes

  • 1 Brendon L. Neuen, MBBS(Hons), is a Clarendon Scholar at the Nuffield Department of Population Health, University of Oxford, UK. Edgar V. Lerma, MD, is clinical professor of medicine at the University of Illinois at Chicago College of Medicine. Joel Topf, MD, is Medical Director of St. Clair Nephrology Research in Roseville, MI.
Restricted access